Tapewire

Nasdaq · USD

VRTX

VERTEX PHARMACEUTICALS INC / MA

Export transactions ↓
Tapewire entity
2875
SEC CIK
0000875320
Parsed reports
2,554

Last 12 months

Inside the activity.

0 purchase rows · 93 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202506
Dec 2025016
Jan 202602
Feb 2026049
Mar 202605
Apr 202601
May 202606
Jun 202605
Jul 202603
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 21, 2017 Filed Jun 23, 2017 20:08 UTC
Chodakewitz JeffreyEVP GMDA, CMO
SaleCommon Stock 5,157 $132.87 $685,210.59
Disclosure

SEC source: 0001209191-17-041635 · doc4.xml · nonDerivative · entry 2

Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,511

F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1.

Read SEC document
June 21, 2017 Filed Jun 23, 2017 20:08 UTC
Chodakewitz JeffreyEVP GMDA, CMO
Exercise / conversionCommon Stock 5,157 $96.87 $499,558.59
Disclosure

SEC source: 0001209191-17-041635 · doc4.xml · nonDerivative · entry 1

Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 127,668

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 21, 2017 Filed Jun 23, 2017 20:10 UTC
Silva Paul MSVP & Corp Controller
Exercise / conversionStock Option (Right to Buy) · Derivative 2,577 $0.00 Strike: $83.36 $0.00
Disclosure

SEC source: 0001209191-17-041640 · doc4.xml · derivative · entry 4

Silva Paul M · CIK 0001446372 · SVP & Corp Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,297

Underlying: Common Stock · 2,577 shares

Expires 2023-07-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vests in 16 quarterly installments from 07/30/2013.

Read SEC document
June 21, 2017 Filed Jun 23, 2017 20:10 UTC
Silva Paul MSVP & Corp Controller
SaleCommon Stock 2,577 $133.36 $343,668.72
Disclosure

SEC source: 0001209191-17-041640 · doc4.xml · nonDerivative · entry 2

Silva Paul M · CIK 0001446372 · SVP & Corp Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,071

F1 · kind: Transaction made pursuant to Mr. Silva's company-approved trading plan under Rule 10b5-1.

Read SEC document
June 21, 2017 Filed Jun 23, 2017 20:10 UTC
Silva Paul MSVP & Corp Controller
Exercise / conversionCommon Stock 2,577 $83.36 $214,818.72
Disclosure

SEC source: 0001209191-17-041640 · doc4.xml · nonDerivative · entry 1

Silva Paul M · CIK 0001446372 · SVP & Corp Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,648

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 08, 2017 Filed Jun 9, 2017 20:07 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 5,320 $0.00 Strike: $125.11 $0.00
Disclosure

SEC source: 0001209191-17-038859 · doc4.xml · derivative · entry 2

Garber Alan M · CIK 0001312907 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,320

Underlying: Common Stock · 5,320 shares

Expires 2027-06-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vests in 16 quarterly installments from 06/08/2017.

Read SEC document
June 08, 2017 Filed Jun 9, 2017 20:07 UTC GrantCommon Stock 2,199 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-038859 · doc4.xml · nonDerivative · entry 1

Garber Alan M · CIK 0001312907 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,199

F1 · shares: Restricted stock unit award that vests in four annual installments from 6/08/2017.

Read SEC document
June 08, 2017 Filed Jun 9, 2017 20:31 UTC Exercise / conversionDeferred Stock Units · Derivative 2,941 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-17-038895 · doc4.xml · derivative · entry 4

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,941 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each deferred stock unit represents one share of common stock and converted into common stock upon the termination of Dr. Boger's service on our board of directors on 06/08/2017.

F1 · price: Each deferred stock unit represents one share of common stock and converted into common stock upon the termination of Dr. Boger's service on our board of directors on 06/08/2017.

F1 · derivative.exercise_date: Each deferred stock unit represents one share of common stock and converted into common stock upon the termination of Dr. Boger's service on our board of directors on 06/08/2017.

F1 · derivative.expiration_date: Each deferred stock unit represents one share of common stock and converted into common stock upon the termination of Dr. Boger's service on our board of directors on 06/08/2017.

Read SEC document
June 08, 2017 Filed Jun 9, 2017 20:31 UTC Exercise / conversionCommon Stock 2,941 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-17-038895 · doc4.xml · nonDerivative · entry 1

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 284,088

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each deferred stock unit represents one share of common stock and converted into common stock upon the termination of Dr. Boger's service on our board of directors on 06/08/2017.

Read SEC document
June 05, 2017 Filed Jun 5, 2017 22:10 UTC
ALTSHULER DAVIDEVP, Global Research and CSO
Exercise / conversionStock Option (Right to Buy) · Derivative 7,500 $0.00 Strike: $72.14 $0.00
Disclosure

SEC source: 0001209191-17-037928 · doc4.xml · derivative · entry 3

ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,500 shares

Expires 2024-05-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Fully vested.

Read SEC document
June 05, 2017 Filed Jun 5, 2017 22:10 UTC
ALTSHULER DAVIDEVP, Global Research and CSO
SaleCommon Stock 7,500 $130.00 $975,000.00
Disclosure

SEC source: 0001209191-17-037928 · doc4.xml · nonDerivative · entry 2

ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,011

F1 · kind: Transaction made pursuant to Mr. Altshuler's company approved trading plan under Rule 10b5-1.

Read SEC document
June 05, 2017 Filed Jun 5, 2017 22:10 UTC
ALTSHULER DAVIDEVP, Global Research and CSO
Exercise / conversionCommon Stock 7,500 $72.14 $541,050.00
Disclosure

SEC source: 0001209191-17-037928 · doc4.xml · nonDerivative · entry 1

ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,511

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 02, 2017 Filed Jun 5, 2017 21:07 UTC SaleCommon Stock 1,176 $128.44 $151,045.44
Disclosure

SEC source: 0001209191-17-037805 · doc4.xml · nonDerivative · entry 2

Bhatia Sangeeta N. · CIK 0001643921 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,953

F2 · kind: Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1.

Read SEC document
June 02, 2017 Filed Jun 5, 2017 21:56 UTC
Lee YuchunDirector
SaleCommon Stock 1,323 $128.44 $169,926.12
Disclosure

SEC source: 0001209191-17-037907 · doc4.xml · nonDerivative · entry 2

Lee Yuchun · CIK 0001334365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,847

F2 · kind: Transaction made pursuant to Mr. Yuchun's company approved trading plan under Rule 10b5-1.

Read SEC document
June 02, 2017 Filed Jun 5, 2017 22:03 UTC
LEIDEN JEFFREY MDirector · CEO & President
Exercise / conversionStock Option (Right to Buy) · Derivative 124,601 $0.00 Strike: $29.98 $0.00
Disclosure

SEC source: 0001209191-17-037920 · doc4.xml · derivative · entry 6

LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 124,601 shares

Expires 2021-12-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Fully vested.

Read SEC document
June 02, 2017 Filed Jun 5, 2017 22:03 UTC
LEIDEN JEFFREY MDirector · CEO & President
Exercise / conversionStock Option (Right to Buy) · Derivative 22,500 $0.00 Strike: $53.85 $0.00
Disclosure

SEC source: 0001209191-17-037920 · doc4.xml · derivative · entry 5

LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 22,500 shares

Expires 2021-05-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Fully vested.

Read SEC document
June 02, 2017 Filed Jun 5, 2017 22:03 UTC
LEIDEN JEFFREY MDirector · CEO & President
SaleCommon Stock 147,101 $129.50 $19,049,579.50
Disclosure

SEC source: 0001209191-17-037920 · doc4.xml · nonDerivative · entry 3

LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 289,642

F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1.

Read SEC document
June 02, 2017 Filed Jun 5, 2017 22:03 UTC
LEIDEN JEFFREY MDirector · CEO & President
Exercise / conversionCommon Stock 124,601 $29.98 $3,735,537.98
Disclosure

SEC source: 0001209191-17-037920 · doc4.xml · nonDerivative · entry 2

LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 436,743

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 02, 2017 Filed Jun 5, 2017 22:03 UTC
LEIDEN JEFFREY MDirector · CEO & President
Exercise / conversionCommon Stock 22,500 $53.85 $1,211,625.00
Disclosure

SEC source: 0001209191-17-037920 · doc4.xml · nonDerivative · entry 1

LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 312,142

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 02, 2017 Filed Jun 5, 2017 22:06 UTC
Arbuckle Stuart AEVP\Chief Commercial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 31,875 $0.00 Strike: $83.36 $0.00
Disclosure

SEC source: 0001209191-17-037923 · doc4.xml · derivative · entry 9

Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,125

Underlying: Common Stock · 31,875 shares

Expires 2023-07-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The option vests in 16 quarterly installments from 07/30/2013.

Read SEC document
June 02, 2017 Filed Jun 5, 2017 22:06 UTC
Arbuckle Stuart AEVP\Chief Commercial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 25,500 $0.00 Strike: $77.31 $0.00
Disclosure

SEC source: 0001209191-17-037923 · doc4.xml · derivative · entry 8

Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,750

Underlying: Common Stock · 25,500 shares

Expires 2024-02-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/05/2014.

Read SEC document
June 02, 2017 Filed Jun 5, 2017 22:06 UTC
Arbuckle Stuart AEVP\Chief Commercial Officer
SaleCommon Stock 57,375 $129.02 $7,402,522.50
Disclosure

SEC source: 0001209191-17-037923 · doc4.xml · nonDerivative · entry 5

Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,467

F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1.

F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $129.02 (range $129.00 to $129.16).

Read SEC document
June 02, 2017 Filed Jun 5, 2017 22:06 UTC
Arbuckle Stuart AEVP\Chief Commercial Officer
Exercise / conversionCommon Stock 31,875 $83.36 $2,657,100.00
Disclosure

SEC source: 0001209191-17-037923 · doc4.xml · nonDerivative · entry 4

Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 188,842

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 02, 2017 Filed Jun 5, 2017 22:06 UTC
Arbuckle Stuart AEVP\Chief Commercial Officer
Exercise / conversionCommon Stock 25,500 $77.31 $1,971,405.00
Disclosure

SEC source: 0001209191-17-037923 · doc4.xml · nonDerivative · entry 3

Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,967

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 01, 2017 Filed Jun 5, 2017 21:09 UTC GrantDeferred Stock Units · Derivative 2,941 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-17-037808 · doc4.xml · derivative · entry 6

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,941

Underlying: Common Stock · 2,941 shares

Expires not disclosed

F4 · derivative.exercise_price: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Boger's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Boger's disability or death.

F2 · price: Upon the vesting of restricted stock units granted to Dr. Boger on June 1, 2016, Dr. Boger deferred the receipt of 2,941 shares of common stock and received instead 2,941 deferred stock units pursuant to the Company's deferred compensation plan. As a result, Dr. Boger is reporting the disposition of 2,941 shares of common stock in exchange for an equal number of deferred stock units.

F4 · derivative.exercise_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Boger's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Boger's disability or death.

F4 · derivative.expiration_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Boger's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Boger's disability or death.

Read SEC document
June 01, 2017 Filed Jun 5, 2017 21:09 UTC GrantStock Option (Right to Buy) · Derivative 5,295 $0.00 Strike: $125.71 $0.00
Disclosure

SEC source: 0001209191-17-037808 · doc4.xml · derivative · entry 5

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,295

Underlying: Common Stock · 5,295 shares

Expires 2027-05-31

F3 · derivative.exercise_date: Fully vested.

Read SEC document
June 01, 2017 Filed Jun 5, 2017 21:09 UTC Disposition to issuerCommon Stock 2,941 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-17-037808 · doc4.xml · nonDerivative · entry 2

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 281,147

F2 · price: Upon the vesting of restricted stock units granted to Dr. Boger on June 1, 2016, Dr. Boger deferred the receipt of 2,941 shares of common stock and received instead 2,941 deferred stock units pursuant to the Company's deferred compensation plan. As a result, Dr. Boger is reporting the disposition of 2,941 shares of common stock in exchange for an equal number of deferred stock units.

Read SEC document
June 01, 2017 Filed Jun 5, 2017 21:09 UTC GrantCommon Stock 2,188 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-037808 · doc4.xml · nonDerivative · entry 1

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 284,088

F1 · shares: Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.

Read SEC document
June 01, 2017 Filed Jun 5, 2017 21:07 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 5,295 $0.00 Strike: $125.71 $0.00
Disclosure

SEC source: 0001209191-17-037805 · doc4.xml · derivative · entry 3

Bhatia Sangeeta N. · CIK 0001643921 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,295

Underlying: Common Stock · 5,295 shares

Expires 2027-05-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Fully vested.

Read SEC document
June 01, 2017 Filed Jun 5, 2017 21:07 UTC GrantCommon Stock 2,188 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-037805 · doc4.xml · nonDerivative · entry 1

Bhatia Sangeeta N. · CIK 0001643921 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,129

F1 · shares: Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.

Read SEC document
June 01, 2017 Filed Jun 5, 2017 21:11 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 5,295 $0.00 Strike: $125.71 $0.00
Disclosure

SEC source: 0001209191-17-037815 · doc4.xml · derivative · entry 2

Kearney Terrence C · CIK 0001289098 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,295

Underlying: Common Stock · 5,295 shares

Expires 2027-05-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Fully vested.

Read SEC document
June 01, 2017 Filed Jun 5, 2017 21:11 UTC GrantCommon Stock 2,188 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-037815 · doc4.xml · nonDerivative · entry 1

Kearney Terrence C · CIK 0001289098 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,629

F1 · shares: Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.

Read SEC document
June 01, 2017 Filed Jun 5, 2017 21:56 UTC
Lee YuchunDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 5,295 $0.00 Strike: $125.71 $0.00
Disclosure

SEC source: 0001209191-17-037907 · doc4.xml · derivative · entry 3

Lee Yuchun · CIK 0001334365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,295

Underlying: Common Stock · 5,295 shares

Expires 2027-05-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Fully vested.

Read SEC document
June 01, 2017 Filed Jun 5, 2017 21:56 UTC
Lee YuchunDirector
GrantCommon Stock 2,188 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-037907 · doc4.xml · nonDerivative · entry 1

Lee Yuchun · CIK 0001334365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,170

F1 · shares: Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.

Read SEC document
June 01, 2017 Filed Jun 5, 2017 22:00 UTC GrantDeferred Stock Units · Derivative 2,941 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-17-037913 · doc4.xml · derivative · entry 4

SACHS BRUCE I · CIK 0001197036 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,275.246

Underlying: Common Stock · 2,941 shares

Expires not disclosed

F4 · derivative.exercise_price: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death.

F2 · price: Upon the vesting of restricted stock units granted to Mr. Sachs on June 1, 2016, Mr. Sachs deferred the receipt of 2,941 shares of common stock and received instead 2,941 deferred stock units pursuant to the Company's deferred compensation plan. As a result, Mr. Sachs is reporting the disposition of 2,941 shares of common stock in exchange for an equal number of deferred stock units.

F4 · derivative.exercise_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death.

F4 · derivative.expiration_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death.

Read SEC document
June 01, 2017 Filed Jun 5, 2017 22:00 UTC GrantStock Option (Right to Buy) · Derivative 5,295 $0.00 Strike: $125.71 $0.00
Disclosure

SEC source: 0001209191-17-037913 · doc4.xml · derivative · entry 3

SACHS BRUCE I · CIK 0001197036 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,295

Underlying: Common Stock · 5,295 shares

Expires 2027-05-31

F3 · derivative.exercise_date: Fully vested.

Read SEC document
June 01, 2017 Filed Jun 5, 2017 22:00 UTC Disposition to issuerCommon Stock 2,941 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-17-037913 · doc4.xml · nonDerivative · entry 2

SACHS BRUCE I · CIK 0001197036 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,398

F2 · price: Upon the vesting of restricted stock units granted to Mr. Sachs on June 1, 2016, Mr. Sachs deferred the receipt of 2,941 shares of common stock and received instead 2,941 deferred stock units pursuant to the Company's deferred compensation plan. As a result, Mr. Sachs is reporting the disposition of 2,941 shares of common stock in exchange for an equal number of deferred stock units.

Read SEC document
June 01, 2017 Filed Jun 5, 2017 22:00 UTC GrantCommon Stock 2,188 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-037913 · doc4.xml · nonDerivative · entry 1

SACHS BRUCE I · CIK 0001197036 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,339

F1 · shares: Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.

Read SEC document
June 01, 2017 Filed Jun 5, 2017 21:59 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 5,295 $0.00 Strike: $125.71 $0.00
Disclosure

SEC source: 0001209191-17-037911 · doc4.xml · derivative · entry 2

MCGLYNN MARGARET G · CIK 0001215126 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,295

Underlying: Common Stock · 5,295 shares

Expires 2027-05-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Fully vested.

Read SEC document
June 01, 2017 Filed Jun 5, 2017 21:59 UTC GrantCommon Stock 2,188 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-037911 · doc4.xml · nonDerivative · entry 1

MCGLYNN MARGARET G · CIK 0001215126 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,217

F1 · shares: Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.

Read SEC document
June 01, 2017 Filed Jun 5, 2017 22:01 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 5,295 $0.00 Strike: $125.71 $0.00
Disclosure

SEC source: 0001209191-17-037914 · doc4.xml · derivative · entry 2

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,295

Underlying: Common Stock · 5,295 shares

Expires 2027-05-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Fully vested.

Read SEC document
June 01, 2017 Filed Jun 5, 2017 22:01 UTC GrantCommon Stock 2,188 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-037914 · doc4.xml · nonDerivative · entry 1

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,394

F1 · shares: Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.

Read SEC document
June 01, 2017 Filed Jun 5, 2017 22:02 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 5,295 $0.00 Strike: $125.71 $0.00
Disclosure

SEC source: 0001209191-17-037916 · doc4.xml · derivative · entry 2

YOUNG WILLIAM D · CIK 0001217420 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,295

Underlying: Common Stock · 5,295 shares

Expires 2027-05-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Fully vested.

Read SEC document
June 01, 2017 Filed Jun 5, 2017 22:02 UTC GrantCommon Stock 2,188 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-037916 · doc4.xml · nonDerivative · entry 1

YOUNG WILLIAM D · CIK 0001217420 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,129

F1 · shares: Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.

Read SEC document
June 01, 2017 Filed Jun 5, 2017 22:05 UTC
SMITH IAN FEVP, CFO & COO
Exercise / conversionStock Option (Right to Buy) · Derivative 10,195 $0.00 Strike: $38.80 $0.00
Disclosure

SEC source: 0001209191-17-037922 · doc4.xml · derivative · entry 12

SMITH IAN F · CIK 0001197032 · EVP, CFO & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,195 shares

Expires 2021-02-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Fully vested.

Read SEC document
June 01, 2017 Filed Jun 5, 2017 22:05 UTC
SMITH IAN FEVP, CFO & COO
Exercise / conversionStock Option (Right to Buy) · Derivative 9,062 $0.00 Strike: $51.75 $0.00
Disclosure

SEC source: 0001209191-17-037922 · doc4.xml · derivative · entry 11

SMITH IAN F · CIK 0001197032 · EVP, CFO & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,062 shares

Expires 2021-07-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Fully vested.

Read SEC document
June 01, 2017 Filed Jun 5, 2017 22:05 UTC
SMITH IAN FEVP, CFO & COO
Exercise / conversionStock Option (Right to Buy) · Derivative 23,789 $0.00 Strike: $37.86 $0.00
Disclosure

SEC source: 0001209191-17-037922 · doc4.xml · derivative · entry 10

SMITH IAN F · CIK 0001197032 · EVP, CFO & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 23,789 shares

Expires 2022-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Fully vested.

Read SEC document
June 01, 2017 Filed Jun 5, 2017 22:05 UTC
SMITH IAN FEVP, CFO & COO
Exercise / conversionStock Option (Right to Buy) · Derivative 18,124 $0.00 Strike: $48.74 $0.00
Disclosure

SEC source: 0001209191-17-037922 · doc4.xml · derivative · entry 9

SMITH IAN F · CIK 0001197032 · EVP, CFO & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 18,124 shares

Expires 2022-07-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Fully vested.

Read SEC document
June 01, 2017 Filed Jun 5, 2017 22:05 UTC
SMITH IAN FEVP, CFO & COO
Exercise / conversionStock Option (Right to Buy) · Derivative 37,383 $0.00 Strike: $45.11 $0.00
Disclosure

SEC source: 0001209191-17-037922 · doc4.xml · derivative · entry 8

SMITH IAN F · CIK 0001197032 · EVP, CFO & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 37,383 shares

Expires 2023-02-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Fully vested.

Read SEC document
June 01, 2017 Filed Jun 5, 2017 22:05 UTC
SMITH IAN FEVP, CFO & COO
SaleCommon Stock 98,553 $124.00 $12,220,572.00
Disclosure

SEC source: 0001209191-17-037922 · doc4.xml · nonDerivative · entry 6

SMITH IAN F · CIK 0001197032 · EVP, CFO & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,238

F1 · kind: Transaction made pursuant to Mr. Smith's company approved trading plan under Rule 10b5-1.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.